title: Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injury.
abstract: Ischaemia-reperfusion (IR) injury is a composite of the injury sustained during a period of reduced or absent blood flow to a tissue or organ and the additional insult sustained upon reperfusion that limits the amount of tissue that can be salvaged. IR injury plays a central role in both native and transplant acute kidney injury (AKI). Native AKI is associated with increased morbidity and mortality in hospital inpatients, and transplant AKI contributes to graft dysfunction, ultimately limiting graft longevity. In this review, we discuss the potential therapeutic benefits of a cost-effective and low-risk intervention, remote ischaemic preconditioning (RIPC), and its applicability in the prevention and reduction of AKI.
authors.affiliation: UCL Centre for Clinical Pharmacology & Therapeutics, University College London, The Rayne Building, University Street, London, WC1E 6JJ, UK, k.veighey@ucl.ac.uk.
authors.forename: Kristin
authors.initials: K
authors.lastname: Veighey
authors.forename: Raymond
authors.initials: R
authors.lastname: MacAllister
mesh_terms: D058186:Acute Kidney Injury / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D000818:Animals; D014943:Global Health; D006084:Graft Rejection / Q000150:complications*; D006801:Humans; D015994:Incidence; D019194:Ischemic Preconditioning / Q000379:methods*; D016377:Organ Transplantation / Q000009:adverse effects*; D015996:Survival Rate / Q000639:trends